Category RSS Feed Posts by category Drug Science en https://www.mind-foundation.org/blog/category/category/drug-science/blog.category.xml Tue, 17 Mar 2026 00:53:00 +0100 Kick-off for a game with extra time: The EPIsoDE scientific symposium with an outlook on psychedelics in medical carehttps://www.mind-foundation.org/blog/symposium-episodeMon, 28 Oct 2024 13:57:15 +0100Henrik Jungaberlehttps://www.mind-foundation.org/blog/symposium-episode The APT Network - Building a Professional Community for Psychedelic Therapistshttps://www.mind-foundation.org/blog/the-apt-networkTue, 24 Sep 2024 12:06:13 +0200Max Wolffhttps://www.mind-foundation.org/blog/the-apt-networkDiscover how the MIND Foundation's Augmented Psychotherapy Training (APT) Network is creating a professional community for psychedelic therapists. With 142 members and growing, the network provides valuable support, collaboration, and development opportunities, advancing the integration of psychedelic therapy into mental health care worldwide. A lid for every pothttps://www.mind-foundation.org/blog/lsd-receptor-bindingTue, 20 Feb 2024 15:13:02 +0100Muad abd el Hayhttps://www.mind-foundation.org/blog/lsd-receptor-bindingLearn about LSD's binding properties and dive into its prolonged effects and therapeutic potential. The Synthetic Toad – How to investigate 5-Meo-DMT in the labhttps://www.mind-foundation.org/blog/5-meo-dmt-syntheticThu, 28 Jul 2022 11:08:00 +0200Johannes ReckwegLukas A. Basedowhttps://www.mind-foundation.org/blog/5-meo-dmt-synthetic5-MeO-DMT & its effects: safety, dosage & therapeutic potential. Learn more in the interview with Johannes Reckweg! ► Read now! Field pharmacology and naturalistic placeboshttps://www.mind-foundation.org/blog/field-pharmacologyWed, 01 Dec 2021 09:26:00 +0100Malin Vedøy UthaugLucca Jaeckelhttps://www.mind-foundation.org/blog/field-pharmacologyEntdecken Sie die faszinierende Welt der Feld-Pharmakologie & wie naturalistische Placebos die psychedelische Therapie beeinflussen. ► Mehr erfahren! Tolerance to LSD – How the brain bolts the doors of perceptionhttps://www.mind-foundation.org/blog/tolerance-to-lsdSat, 16 Oct 2021 00:01:00 +0200Tobias Buchbornhttps://www.mind-foundation.org/blog/tolerance-to-lsdExplore the mechanisms and implications of LSD tolerance, including the role of glutamate receptors and the benefits and risks of long-term microdosing. How and why could MDMA-assisted psychotherapy treat PTSD?https://www.mind-foundation.org/blog/mdma-ptsdFri, 03 Sep 2021 16:40:00 +0200Samuli Kangaslampi, Ph.D.https://www.mind-foundation.org/blog/mdma-ptsdUnderstand PTSD, existing treatment strategies, and why MDMA-assisted psychotherapy holds such promise for treating patients with related symptoms. Leave the trips alonehttps://www.mind-foundation.org/blog/psychedelic-neuroscience-antidepressantFri, 25 Jun 2021 12:13:00 +0200Vlad Nicolescuhttps://www.mind-foundation.org/blog/psychedelic-neuroscience-antidepressantIs a "psychedelic trip" needed for the therapeutic benefits of psychedelics? Explore this controversy and a neuroscientific case arguing in favor. The future of psychedelics in Alzheimer’s disease treatmenthttps://www.mind-foundation.org/blog/psychedelics-alzheimers-disease-treatmentSat, 12 Jun 2021 01:52:00 +0200Milena Marinkovićhttps://www.mind-foundation.org/blog/psychedelics-alzheimers-disease-treatmentDiscover how psychedelics could offer new treatments for Alzheimer's disease and their potential impact on brain health and cognitive function. How do antidepressants really work?https://www.mind-foundation.org/blog/antidepressants-neurobiologyFri, 28 May 2021 16:09:00 +0200Lukas A. BasedowEero Castrénhttps://www.mind-foundation.org/blog/antidepressants-neurobiologyA new study takes a closer look at classic antidepressants like SSRIs & SNRIs. ► Read the interview with Prof. Castrén about antidepressants!